|
|
|
501-1,000 employees
View all
|
|
Biotechnology
|
|
11040 Roselle St, San Diego, California 92121, US
|
|
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our client’s needs. Learn more: www.AjiBio-Pharma.com
|
Daigaku Hideura is the CEO of Ajinomoto Bio-Pharma Services.
The decision makers in Ajinomoto Bio-Pharma Services are Bert Barbosa, Brian Blagg, Darwin Richardson, etc. Click to Find Ajinomoto Bio-Pharma Services decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.